Generic Anemia Drug Allowed
640400
Novartis has become the first company to win approval for a copy of Johnson & Johnsonâs Eprex anemia treatment, allowing it to offer cheaper versions to Europeans.
471781
The company is ready to handle competition from generics.
189562
The Food and Drug Administration warned yesterday that anemia-fighting drugs called erythropoietins, which had $10 billion in U.S. sales last year, are being used so aggressively that they may be harming some patients.
665283
Doctors should stop using the anemia  drug Procrit, made by Johnson & Johnson's Ortho Biotech  Products L.P., if an oxygen-carrying agent in a patient's blood  reaches high levels, the company said in documents released on  Wednesday.
220529
Amgen Inc. has added a warning to its anemia drug, Aranesp, for kidney dialysis and cancer patients after studies on similar drugs showed higher doses can cause blood clots and death, the company said a letter released on Friday.
635540
WASHINGTON -- Federal regulators charged with approving generic versions of the world's most expensive drugs should follow the lead of their cautious European counterparts, according to Senator Edward M. Kennedy . In Europe, requirements for approval are tailored to the complexity of an experimental drug and can include clinical trials that cost millions for generic manufacturers to conduct.
111899
WASHINGTON -- A major maker of generic AIDS medicines voluntarily removed all its antiretrovirals from the World Health Organization's list of approved drugs yesterday, a move that could potentially affect tens of thousands of AIDS patients in poor countries who have only recently entered treatment.
212231
Cancer doctors seek to loosen federal restrictions on anemia drugs that carry potentially deadly side effects, saying the tight payment guidelines for treatments made by Amgen and Johnson and Johnson are ultimately bad for patients.
222069
The first generic version of Lexapro, one of the most widely prescribed antidepressants, with more than $2 billion in sales last year, received federal approval Monday.
405026
Five nations launched an  initiative on Tuesday to raise at least $300 million next year  to buy generic drugs at steep volume discounts to fight AIDS,  tuberculosis and malaria in developing countries.
130541
The legal outcome could help protect Amgenâs multibillion dollar anemia drug franchise in the U.S. by blocking Rocheâs plan to introduce a competing medicine.
349616
WASHINGTON -- Greater numbers of seriously ill patients could get experimental medicines under proposed federal guidelines released Monday that also would allow drug companies to charge for the medicines.
3117
India and China, countries where the Food and Drug Administration rarely conducts quality-control inspections, have become major suppliers of low-cost drugs and drug ingredients to American consumers. Analysts say their products are becoming pervasive in the generic and over-the-counter marketplace.
586343
U.S. regulators said on Thursday they were reviewing two recent studies that provided more evidence of serious risks for some cancer patients treated with anemia drugs sold by Amgen Inc  and Johnson & Johnson .
685744
The Medicines Company reacquires its own drug.
329407
Responding to a spate of deaths in clinical trials, the Food and Drug Administration yesterday issued its most severe warning possible for drugs widely used to treat anemia in kidney disease patients and cancer patients undergoing chemotherapy.
214179
WASHINGTON -- Some influential members of Congress are renewing their pledge to help speed generic versions of the world's most expensive drugs to market.